Anna Mowry

Chief Financial Officer

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 1 buy · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (5 ops.)

€240k

▼ Sales (0 ops.)

—

Latest filing published 02 Jun 2025 for Nautilus Biotechnology, Inc., €10k. Read the official filing

Filing timeline

BuySale

Anna Mowry

Insider track record

Disclosed buys

Disclosed sells

T+90 hit rate

T+90 mean return

-25.0%

Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Anna Mowry: trading record in brief

Anna Mowry, listed as finance chief, appears in our data through filings on Nautilus Biotechnology, Inc. shares, published by SEC (Form 4). We count 5 filings; the first trade dates from 12 August 2021 and the latest from 29 May 2025.

Every open-market trade on record is a purchase: 5 purchases worth €240k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2025, the count stands at 1 purchase and no sales.

In size, the median ticket on the buying side is €40k. Clusters matter here: 4 out of 5 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

The latest filing, published on 2 June 2025, reports an open-market purchase of €10k in Nautilus Biotechnology, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.